Quasispecies and Drug Resistance - Wikidata - awgldk - TriplyDB

Quasispecies and Drug Resistance

Quasispecies and Drug Resistance

http://www.wikidata.org/entity/Q56957250

about

Quasispecies and Drug Resistance

http://www.wikidata.org/entity/Q56957250

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2017

@uk

name

Quasispecies and Drug Resistance

@en

Quasispecies and Drug Resistance

@nl

type

label

Quasispecies and Drug Resistance

@en

Quasispecies and Drug Resistance

@nl

prefLabel

Quasispecies and Drug Resistance

@en

Quasispecies and Drug Resistance

@nl

P1476

Q56957250-FCD0E397-647E-4ED2-B7E2-24A526EF82C2

P2093

Q56957250-82E7C779-F940-4D0F-A052-5F8F2EB1D075

Q56957250-BCBECCBB-BFCD-4C43-B581-89D8DD7B0AC5

Q56957250-C0EF2E7E-650A-4D53-BD5A-F6FB14A02146

Q56957250-D452C3BA-4ECD-4864-BAD2-9DAC89962D5C

P2860

Q56957250-05D3DE7F-92AF-49FC-88F0-0ABB07493BED

Q56957250-06907CB0-A295-4E5E-9719-FEC689377785

Q56957250-0801476A-133B-4FAD-AB9E-E23F3D042AE7

Q56957250-09E5FDCC-A6D7-48B6-BD45-4291F057D078

Q56957250-0A7D7716-151B-4265-84A8-866C875F95DE

Q56957250-0E96A6C4-4BD1-4A85-BC13-08C89D32B9CA

Q56957250-101633CA-E4CD-4C11-A6D2-B7810E5D3579

Q56957250-108395B4-37AE-497E-A98E-4AE7B3C52CC9

Q56957250-1300D72A-E90D-4FA4-A165-631509E68FF7

Q56957250-14D303FF-CD01-4F4D-BE2E-E35F45B2715C

P304

Q56957250-BCCD10A5-153D-4CA1-9A82-222832506534

P31

Q56957250-04A87402-9B1D-448A-8694-18DC5F07EF2E

P356

Q56957250-0DB7D23B-2778-40B0-9AEB-81BE5A8AAA54

P50

Q56957250-D9BF2049-F97B-485F-B233-4B6A231B3648

Q56957250-F1465B26-3D6B-4756-97AF-EE1C96FA33B0

P577

Q56957250-EE66A39D-5444-4008-B4C4-372B6B38977A

P356

978-1-4939-0694-9_1

P1476

Quasispecies and Drug Resistance

@en

P2093

Celia Perales

http://www.w3.org/2001/XMLSchema#string

Julie Sheldon

http://www.w3.org/2001/XMLSchema#string

Luis Menéndez-Arias

http://www.w3.org/2001/XMLSchema#string

Nathan M. Beach

http://www.w3.org/2001/XMLSchema#string

P2860

Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis

Structural basis of HIV-1 resistance to AZT by excision

Boceprevir for previously treated chronic HCV genotype 1 infection

Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice

Regulation of hepatic innate immunity by hepatitis C virus

Viral quasispecies evolution

The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796

Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo

P304

123-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-0694-9_1

http://www.w3.org/2001/XMLSchema#string

P50

Esteban Domingo

Ana Maria Ortega-Prieto

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime